Adial Pharmaceuticals
ADIL
16 hedge funds and large institutions have $215K invested in Adial Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 3 closing their positions.
1,110% more capital inflows, than outflows
Capital inflows: $160K | Capital outflows: $13.3K
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
1.71% more ownership
Funds ownership: 1.08% → 2.8% (+1.7%)
0% more funds holding
Funds holding: 16 → 16 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$56.1K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$55.7K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$37.1K |
| 4 |
Two Sigma Securities
New York
|
+$5.01K |
| 5 |
Private Management Group
Irvine,
California
|
+$3.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$4.87K |
| 2 |
Two Sigma Investments
New York
|
-$3.26K |
| 3 |
HRT Financial
New York
|
-$3.08K |
| 4 |
Citigroup
New York
|
-$1.2K |
| 5 |
Stone House Investment Management
Tunkhannock,
Pennsylvania
|
-$816 |
ADIL Hedge Fund Activity: Q3 2025 in Review
16 of the 7,650 institutional investors tracked by Wall St. Rank reported a position in Adial Pharmaceuticals (ADIL) for Q3 2025, worth a combined $215K — up 203% from $70.8K a quarter earlier.
Fund positioning in ADIL was balanced in Q3 2025: 3 funds opened new positions, 3 closed out, 5 added to existing stakes and 3 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $56.1K. The largest seller was Jane Street, cutting an estimated $4.87K.
- 16 institutional investors held Adial Pharmaceuticals (ADIL) as of Q3 2025, unchanged from Q2 2025.
- Funds reported $215K of Adial Pharmaceuticals stock for Q3 2025, up 203% quarter-over-quarter.
- 3 funds opened new Adial Pharmaceuticals positions in Q3 2025 and 3 closed out, a net change of 0 holders.
- The largest Adial Pharmaceuticals buyer in Q3 2025 was Citadel Advisors, an estimated $56.1K added.
- The largest Adial Pharmaceuticals seller in Q3 2025 was Jane Street, an estimated $4.87K sold.
Based on aggregated 13F filings for Q3 2025.